Identification of the Effect of Multiple Polymorphisms on the Pharmacokinetics of Simvastatin and Simvastatin Acid Using a Population‐Modeling Approach. Issue 1 (5th March 2014)
- Record Type:
- Journal Article
- Title:
- Identification of the Effect of Multiple Polymorphisms on the Pharmacokinetics of Simvastatin and Simvastatin Acid Using a Population‐Modeling Approach. Issue 1 (5th March 2014)
- Main Title:
- Identification of the Effect of Multiple Polymorphisms on the Pharmacokinetics of Simvastatin and Simvastatin Acid Using a Population‐Modeling Approach
- Authors:
- Tsamandouras, N
Dickinson, G
Guo, Y
Hall, S
Rostami‐Hodjegan, A
Galetin, A
Aarons, L - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The aim of this work was to develop a joint population pharmacokinetic model for simvastatin (SV) and its active metabolite, simvastatin acid (SVA), that incorporates the effects of multiple genetic polymorphisms and clinical/demographic characteristics. SV/SVA plasma concentrations, demographic/clinical data, and genotypes for 18 genetic variants were collected from 74 individuals (three clinical trials) and analyzed using a nonlinear mixed‐effects modeling approach. The structural model that best described the data included a two‐ and a one‐compartment disposition model for SV and SVA, respectively. Age, weight, Japanese ethnicity, and seven genetic polymorphisms—rs4149056 (<italic>SLCO1B1</italic>), rs776746 (<italic>CYP3A5</italic>), rs12422149 (<italic>SLCO2B1</italic>), rs2231142 (<italic>ABCG2</italic>), rs4148162 (<italic>ABCG2</italic>), rs4253728 (<italic>PPARA</italic>), and rs35599367 (<italic>CYP3A4</italic>)—were identified as significantly affecting model parameters. The developed model was used to assess combinations of these covariates, highlighting specific risk factors associated with altered SV/SVA pharmacokinetics, and consequently myopathy cases that cannot be solely attributed to the rs4149056 CC genotype.</p> <p> <italic>Clinical Pharmacology &amp; Therapeutics</italic> (2014); <bold>96</bold> 1, 90–100. doi:<ext-link ext-link-type="doi" xlink:type="simple"<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The aim of this work was to develop a joint population pharmacokinetic model for simvastatin (SV) and its active metabolite, simvastatin acid (SVA), that incorporates the effects of multiple genetic polymorphisms and clinical/demographic characteristics. SV/SVA plasma concentrations, demographic/clinical data, and genotypes for 18 genetic variants were collected from 74 individuals (three clinical trials) and analyzed using a nonlinear mixed‐effects modeling approach. The structural model that best described the data included a two‐ and a one‐compartment disposition model for SV and SVA, respectively. Age, weight, Japanese ethnicity, and seven genetic polymorphisms—rs4149056 (<italic>SLCO1B1</italic>), rs776746 (<italic>CYP3A5</italic>), rs12422149 (<italic>SLCO2B1</italic>), rs2231142 (<italic>ABCG2</italic>), rs4148162 (<italic>ABCG2</italic>), rs4253728 (<italic>PPARA</italic>), and rs35599367 (<italic>CYP3A4</italic>)—were identified as significantly affecting model parameters. The developed model was used to assess combinations of these covariates, highlighting specific risk factors associated with altered SV/SVA pharmacokinetics, and consequently myopathy cases that cannot be solely attributed to the rs4149056 CC genotype.</p> <p> <italic>Clinical Pharmacology &amp; Therapeutics</italic> (2014); <bold>96</bold> 1, 90–100. doi:<ext-link ext-link-type="doi" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">10.1038/clpt.2014.55</ext-link></p> </abstract> … (more)
- Is Part Of:
- Clinical pharmacology & therapeutics. Volume 96:Issue 1(2014)
- Journal:
- Clinical pharmacology & therapeutics
- Issue:
- Volume 96:Issue 1(2014)
- Issue Display:
- Volume 96, Issue 1 (2014)
- Year:
- 2014
- Volume:
- 96
- Issue:
- 1
- Issue Sort Value:
- 2014-0096-0001-0000
- Page Start:
- 90
- Page End:
- 100
- Publication Date:
- 2014-03-05
- Subjects:
- Pharmacology -- Periodicals
Therapeutics -- Periodicals
615.5 - Journal URLs:
- http://www.nature.com/clpt/index.html ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1532-6535 ↗
http://www.nature.com/ ↗
http://firstsearch.oclc.org ↗
http://www.mosby.com/cpt ↗
http://www.sciencedirect.com/science/journal/00099236 ↗
http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchdbfor=home&id=cp ↗ - DOI:
- 10.1038/clpt.2014.55 ↗
- Languages:
- English
- ISSNs:
- 0009-9236
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.330000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3625.xml